Kingfa Science (KINGFA) | Financial Analysis & Statements
Kingfa Science & Technology Co., Ltd. Mid-cap Basic Materials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
4.6B
Gross Profit
1.0B
22.30%
Operating Income
516.1M
11.17%
Net Income
397.9M
8.61%
EPS (Diluted)
₹32.86
Balance Sheet Metrics
Total Assets
11.6B
Total Liabilities
4.3B
Shareholders Equity
7.3B
Debt to Equity
0.59
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Kingfa Science Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 17.4B | 14.9B | 14.0B | 10.5B | 6.3B |
| Cost of Goods Sold | 14.0B | 12.0B | 11.6B | 8.9B | 5.5B |
| Gross Profit | 3.4B | 2.8B | 2.4B | 1.5B | 790.3M |
| Gross Margin % | 19.6% | 19.1% | 17.3% | 14.7% | 12.6% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 674.1M | 584.8M | 498.4M | 331.6M | 277.5M |
| Other Operating Expenses | 1.5M | 58.1M | 72.6M | 46.8M | -4.3M |
| Total Operating Expenses | 675.6M | 642.9M | 571.1M | 378.4M | 273.1M |
| Operating Income | 2.1B | 1.7B | 1.5B | 829.1M | 231.3M |
| Operating Margin % | 12.2% | 11.5% | 10.6% | 7.9% | 3.7% |
| Non-Operating Items | |||||
| Interest Income | 5.5M | 10.0M | 12.9M | 8.1M | 10.9M |
| Interest Expense | 56.8M | 46.0M | 50.1M | 39.5M | 25.6M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 2.1B | 1.6B | 1.1B | 413.4M | 118.5M |
| Income Tax | 532.2M | 416.7M | 281.8M | 107.1M | 65.3M |
| Effective Tax Rate % | 25.8% | 25.4% | 25.7% | 25.9% | 55.1% |
| Net Income | 1.5B | 1.2B | 814.1M | 306.3M | 53.2M |
| Net Margin % | 8.8% | 8.2% | 5.8% | 2.9% | 0.8% |
| Key Metrics | |||||
| EBITDA | 2.4B | 1.9B | 1.3B | 826.2M | 322.8M |
| EPS (Basic) | ₹126.22 | ₹101.17 | ₹67.22 | ₹25.29 | ₹4.39 |
| EPS (Diluted) | ₹126.22 | ₹101.17 | ₹67.22 | ₹25.29 | ₹4.39 |
| Basic Shares Outstanding | 12111000 | 12111000 | 12111000 | 12111000 | 12111000 |
| Diluted Shares Outstanding | 12111000 | 12111000 | 12111000 | 12111000 | 12111000 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Kingfa Science Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 234.8M | 50.0M | 24.0M | 85.8M | 37.4M |
| Short-term Investments | 7.2M | 6.4M | 228.3M | 215.1M | 210.6M |
| Accounts Receivable | 4.5B | 4.0B | 3.6B | 2.8B | 2.1B |
| Inventory | 3.0B | 2.4B | 2.9B | 2.6B | 1.4B |
| Other Current Assets | 1.0M | 5.3M | 13.0M | 11.8M | -1.0K |
| Total Current Assets | 8.5B | 7.3B | 7.4B | 6.1B | 4.1B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 99.1M | 74.1M | 74.7M | 74.7M | 61.2M |
| Goodwill | 30.0K | 71.0K | 46.0K | 94.0K | 202.0K |
| Intangible Assets | 30.0K | 71.0K | 46.0K | 94.0K | 202.0K |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 22.5M | 32.8M | 67.1M | -1.0K | 2.0K |
| Total Non-Current Assets | 3.0B | 2.7B | 2.7B | 2.7B | 2.6B |
| Total Assets | 11.6B | 9.9B | 10.1B | 8.8B | 6.7B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 3.5B | 3.5B | 4.7B | 4.3B | 2.2B |
| Short-term Debt | 409.4M | 310.9M | 394.8M | 250.3M | 431.3M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 8.6M | 35.1M | 45.2M | 8.1M | 1.2M |
| Total Current Liabilities | 4.2B | 4.0B | 5.4B | 4.7B | 2.8B |
| Non-Current Liabilities | |||||
| Long-term Debt | 20.6M | 14.6M | 29.6M | 168.8M | 243.8M |
| Deferred Tax Liabilities | 16.7M | 11.9M | 8.0M | 41.5M | 39.0M |
| Other Non-Current Liabilities | - | - | 11.2M | 11.3M | -1.0K |
| Total Non-Current Liabilities | 48.3M | 37.6M | 49.0M | 245.2M | 325.7M |
| Total Liabilities | 4.3B | 4.1B | 5.4B | 5.0B | 3.2B |
| Equity | |||||
| Common Stock | 121.1M | 121.1M | 121.1M | 121.1M | 121.1M |
| Retained Earnings | 4.5B | 3.1B | 1.9B | 1.1B | 803.1M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 7.3B | 5.9B | 4.7B | 3.8B | 3.5B |
| Key Metrics | |||||
| Total Debt | 430.0M | 325.5M | 424.3M | 419.1M | 675.1M |
| Working Capital | 4.3B | 3.2B | 2.0B | 1.4B | 1.2B |
Balance Sheet Composition
Kingfa Science Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 2.1B | 1.6B | 1.1B | 413.4M | 118.5M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -1.1B | -104.3M | -1.4B | -2.0B | -522.3M |
| Operating Cash Flow | 993.8M | 1.6B | -237.5M | -1.5B | -387.6M |
| Investing Activities | |||||
| Capital Expenditures | -303.1M | -208.7M | -244.8M | -189.0M | -150.6M |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | - | 0 | -8.4M | - | - |
| Investment Sales | 615.0K | 215.3M | 0 | - | - |
| Investing Cash Flow | -302.4M | 4.8M | -253.2M | -189.0M | -150.6M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -120.5M | - | - | - | - |
| Debt Issuance | - | - | - | - | 208.2M |
| Debt Repayment | - | 0 | -143.8M | -92.4M | - |
| Financing Cash Flow | 20.6M | 0 | -287.5M | -92.4M | 208.2M |
| Free Cash Flow | 295.9M | -47.8M | 27.0M | 189.3M | -169.7M |
| Net Change in Cash | 711.9M | 1.6B | -778.2M | -1.8B | -330.0M |
Cash Flow Trend
Kingfa Science Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
37.79
Price to Book
5.05
Price to Sales
3.47
PEG Ratio
2.27
Profitability Ratios
Profit Margin
8.90%
Operating Margin
13.35%
Return on Equity
20.98%
Return on Assets
13.23%
Financial Health
Current Ratio
2.94
Debt to Equity
1.44
Beta
0.64
Per Share Data
EPS (TTM)
₹127.71
Book Value per Share
₹955.31
Revenue per Share
₹1,430.17
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| KINGFA | 66.6B | 37.79 | 5.05 | 20.98% | 8.90% | 1.44 |
| Asian Paints | 2.4T | 62.11 | 12.16 | 18.28% | 11.10% | 17.61 |
| Pidilite Industries | 1.4T | 62.22 | 14.87 | 20.85% | 16.19% | 4.54 |
| Atul | 198.1B | 33.01 | 3.32 | 8.55% | 9.81% | 3.14 |
| ACUTAAS CHEMICALS | 196.1B | 68.49 | 13.88 | 12.02% | 23.62% | 0.58 |
| Ami Organics | 190.1B | 119.06 | - | 12.15% | 45.16% | 0.01 |
Financial data is updated regularly. All figures are in the company's reporting currency.





